The impact of early versus late anticonvulsant reduction after ketogenic diet initiation

Area of Science:

• Pediatric Neurology
• Dietary Therapies

Background:

• The optimal timing for reducing anticonvulsant medications in children initiating the ketogenic diet remains uncertain.
• The ketogenic diet is an established therapy for refractory epilepsy in children.

Purpose of the Study:

• To investigate the safety and efficacy of early versus late anticonvulsant reduction in children on the ketogenic diet.
• To compare seizure reduction rates, diet duration, and adherence between early and late tapering groups.

Main Methods:

• Retrospective review of 81 children initiated on the ketogenic diet over a 2-year period.
• Analysis of medication tapering within the first 6 months of diet initiation.
• Comparison of outcomes between patients with early (within 1 month) and late anticonvulsant reduction.

Main Results:

• 65% of patients had their medications tapered within 6 months of starting the ketogenic diet.
• Early tapering (n=30) showed no significant difference in >90% seizure reduction at 3 months compared to late tapering (n=23) (47% vs 48%).
• No significant differences were observed in diet duration, adherence, or improved alertness between early and late tapering groups. Transient seizure increases occurred in 17% during tapering, irrespective of timing, but all achieved >50% seizure reduction at 3 months.

Conclusions:

• Early reduction of anticonvulsants in children on the ketogenic diet is safe and well-tolerated.
• Early tapering does not offer a specific advantage over later tapering regarding seizure control or diet outcomes.
• Further research may explore specific patient subgroups that could benefit from earlier medication reduction.